Trying to separate three different claims about BPC-157: that it is the right molecule, that it is the right dose, and that it does something useful.
Mechanism is not outcome, and a plausible pathway is the most expensive kind of evidence there is.
Loose evidence is not the same as no evidence and people overcorrect in both directions.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
Vial content, sterility and reconstitution are three separate questions and the certificate answers about one of them.
Posting to be argued with, mainly.
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.
Three questions kill most of the confidence in a thread like this: sample size, blinding, who paid.
Narrow conclusion. Three weeks in on BPC-157 and it lines up.
Underdosing and tolerance are indistinguishable from the inside, and everyone picks the flattering explanation.
Test one thing at a time. It feels slower and it is the only way to learn anything.